UnknownNCT03000335

Evaluation of ProALL miRs in Blood Specimen for Prediction of ALL Relapse Risk

Studying Acute lymphoblastic leukemia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Curewize Health Ltd.
Principal Investigator
Isaac Yaniv, MD
Schneider Children's Medical Center, Israel
Enrollment
65 enrolled
Eligibility
2-19 years · All sexes
Timeline
20162021

Study locations (2)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03000335 on ClinicalTrials.gov

Other trials for Acute lymphoblastic leukemia

Additional recruiting or active studies for the same condition.

See all trials for Acute lymphoblastic leukemia

← Back to all trials